| HVIVO PLC LS-,001 |
| Großbritannien |
| Gesundheit |
| GB00B9275X97 / A1KAME |
| CRO (Frankfurt) |
| FRA:CRO, ETR:CRO, CRO:GR |
| - |
| https://hvivo.com/ |
|
Hvivo Plc is a pioneering entity in the clinical research and pharmaceutical development landscape. Its core function is to conduct human challenge studies, which involve intentionally exposing healthy volunteers to a particular pathogen to study inf..
>Volltext.. |
| 48.88 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| 3.08% |
| 3.42% |
| 15.05.25 - 0.0023036€ 18.04.24 - 0.0023036€ >weitere anzeigen... |
| - |
| HVIVO, OPEN ORPHAN |
| 04.04.26 |
|